Octant
Developing synthetic technology and applying next-generation DNA sequencing, gene synthesis, and gene editing to discover safer, more effective, cheaper drugs
69 employees · est. 2017 · Emeryville, United States
Recursion
Decoding Biology to Radically Improve Lives
764 employees · est. 2013 · Salt Lake City, United State...
Recursion is the older company (2017 vs 2013); Recursion is the larger of the two.
Side-by-Side Comparison
| Metric | Octant | Recursion |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2013 older |
| Headquarters | ||
| Headquarters | Emeryville, United States | Salt Lake City, United States |
| Employees | ||
| Employees | 69 | 764 larger |
| Industry | ||
| Industry | Biotechnology, Life Sciences | AI, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | IPO |
| Total Funding | ||
| Total Funding | $119.94M | $1.30B |
| Funding Rounds | ||
| Funding Rounds | 5 | 17 |
| Services | ||
| Services | Engineering precision medicines, Clinical research and development, Preclinical studies, Targeting complex cellular mechanisms | AI-driven solutions in drug discovery, Development of treatments for oncology and rare diseases, Collaborations with pharmaceutical and tech companies, Building and utilizing scalable data models |
| Target Customers | ||
| Target Customers | Patients with genetic diseases, Individuals with Retinitis Pigmentosa, Cancer patients, Healthcare providers looking for innovative treatments | Pharmaceutical companies, Biotech researchers, Clinical institutions, Healthcare providers focusing on oncology and rare diseases |
| Taxonomy | ||
| Taxonomy | Synthetic Technology, Next-Generation DNA Sequencing, Gene Synthesis, Gene Editing, Small Molecule Drug Development, Cell Engineering, High-Throughput Chemistry, Automation In Drug Discovery, Rare Disease Drug Development, Oncology Drug Discovery, Immunology Drug Development, Synthetic Biology, Genome Engineering, Computational Biology, Machine Learning In Biotechnology | TechBio, Clinical-stage Biotechnology, Biological And Chemical Datasets, Machine Learning And AI Algorithms, Drug Discovery, Recursion OS, Phenomics, Drug Repurposing, Rare Diseases, Immuno-oncology, Diseases Of Aging, Automation In Biology, Data Science In Healthcare, Neuroscience |
| Website | ||
| Website | octant.bio | recursion.com |
About Octant
Octant stands at the forefront of the Biotechnology and Life Sciences sectors, leveraging cutting-edge technologies to transform drug discovery. Founded in 2017 and headquartered in the United States, Octant focuses on developing synthetic technology and applying next-generation DNA sequencing, gene...
About Recursion
Recursion, a clinical-stage TechBio company established in 2013, is pioneering advancements in biology with its mission to decode biology to radically improve lives. The company, traded on NASDAQ under the ticker RXRX, operates at the intersection of AI, Biotechnology, Health and Wellness, Pharmaceu...
We will tell you when either one moves
BounceWatch watches Octant and Recursion for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Octant and Recursion — by email.
Frequently Asked Questions
Compare Octant with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Octant on 15 Jun 2026, and Recursion on 24 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.